Beck Mack & Oliver LLC Baxter International Inc Transaction History

Beck Mack & Oliver LLC

  • $4.25 Billion
  • Q2 2024

A detailed history of Beck Mack & Oliver LLC transactions in Baxter International Inc stock. As of the latest transaction made, Beck Mack & Oliver LLC holds 39,435 shares of BAX stock, worth $1.55 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
39,435
Previous 39,985 1.38%
Holding current value
$1.55 Million
Previous $1.71 Million 22.78%
% of portfolio
0.03%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$32.87 - $43.55 $18,078 - $23,952
-550 Reduced 1.38%
39,435 $1.32 Million
Q1 2024

May 14, 2024
SELL
$37.88 - $43.77 $201,180 - $232,462
-5,311 Reduced 11.73%
39,985 $1.71 Million
Q4 2023

Feb 14, 2024
SELL
$31.71 - $38.95 $535,074 - $657,242
-16,874 Reduced 27.14%
45,296 $1.75 Million
Q3 2023

Nov 13, 2023
SELL
$37.32 - $49.29 $264,039 - $348,726
-7,075 Reduced 10.22%
62,170 $2.35 Million
Q2 2023

Aug 08, 2023
SELL
$39.98 - $47.68 $179,910 - $214,560
-4,500 Reduced 6.1%
69,245 $3.15 Million
Q1 2023

May 15, 2023
SELL
$37.58 - $52.57 $505,413 - $707,013
-13,449 Reduced 15.42%
73,745 $2.99 Million
Q4 2022

Feb 14, 2023
SELL
$49.7 - $57.71 $548,141 - $636,483
-11,029 Reduced 11.23%
87,194 $4.44 Million
Q3 2022

Nov 10, 2022
SELL
$53.86 - $66.8 $259,066 - $321,308
-4,810 Reduced 4.67%
98,223 $5.29 Million
Q2 2022

Aug 12, 2022
SELL
$63.83 - $80.0 $1.23 Million - $1.54 Million
-19,230 Reduced 15.73%
103,033 $6.62 Million
Q1 2022

May 16, 2022
SELL
$76.85 - $89.45 $1.8 Million - $2.09 Million
-23,402 Reduced 16.07%
122,263 $9.48 Million
Q4 2021

Jan 28, 2022
SELL
$74.57 - $87.19 $12.9 Million - $15 Million
-172,501 Reduced 54.22%
145,665 $12.5 Million
Q3 2021

Nov 04, 2021
SELL
$73.77 - $83.61 $827,035 - $937,351
-11,211 Reduced 3.4%
318,166 $25.6 Million
Q2 2021

Jul 28, 2021
BUY
$80.5 - $88.01 $1.79 Million - $1.96 Million
22,225 Added 7.24%
329,377 $26.5 Million
Q1 2021

May 11, 2021
SELL
$76.38 - $86.03 $2.96 Million - $3.34 Million
-38,791 Reduced 11.21%
307,152 $25.9 Million
Q4 2020

Feb 10, 2021
SELL
$75.39 - $82.36 $1.92 Million - $2.1 Million
-25,448 Reduced 6.85%
345,943 $27.8 Million
Q3 2020

Nov 02, 2020
SELL
$78.33 - $90.73 $250,656 - $290,336
-3,200 Reduced 0.85%
371,391 $29.9 Million
Q2 2020

Aug 10, 2020
SELL
$78.66 - $94.14 $1.01 Million - $1.21 Million
-12,864 Reduced 3.32%
374,591 $32.3 Million
Q1 2020

May 05, 2020
SELL
$71.57 - $93.3 $5.46 Million - $7.12 Million
-76,325 Reduced 16.46%
387,455 $31.5 Million
Q4 2019

Feb 07, 2020
SELL
$76.7 - $88.45 $832,962 - $960,567
-10,860 Reduced 2.29%
463,780 $38.8 Million
Q3 2019

Nov 06, 2019
SELL
$81.4 - $89.78 $2.13 Million - $2.35 Million
-26,159 Reduced 5.22%
474,640 $41.5 Million
Q2 2019

Aug 13, 2019
SELL
$73.44 - $82.41 $1.59 Million - $1.79 Million
-21,711 Reduced 4.16%
500,799 $41 Million
Q1 2019

May 02, 2019
SELL
$64.48 - $81.31 $1.32 Million - $1.66 Million
-20,447 Reduced 3.77%
522,510 $42.5 Million
Q4 2018

Feb 04, 2019
SELL
$61.45 - $77.8 $2.38 Million - $3.02 Million
-38,799 Reduced 6.67%
542,957 $35.7 Million
Q3 2018

Oct 29, 2018
SELL
$70.71 - $77.75 $12.6 Million - $13.9 Million
-178,652 Reduced 23.49%
581,756 $44.8 Million
Q2 2018

Jul 25, 2018
SELL
$63.43 - $75.41 $1.34 Million - $1.59 Million
-21,092 Reduced 2.7%
760,408 $0
Q1 2018

Apr 25, 2018
SELL
$62.56 - $72.26 $2.2 Million - $2.55 Million
-35,241 Reduced 4.31%
781,500 $0
Q4 2017

Feb 02, 2018
SELL
$61.45 - $66.05 $2.66 Million - $2.86 Million
-43,307 Reduced 5.04%
816,741 $0
Q3 2017

Oct 27, 2017
BUY
$59.5 - $64.61 $51.2 Million - $55.6 Million
860,048
860,048 $0

Others Institutions Holding BAX

# of Institutions
981
Shares Held
446M
Call Options Held
2.22M
Put Options Held
3.04M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Beck Mack & Oliver LLC Portfolio

Follow Beck Mack & Oliver LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email